Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

OBJECTIVES: The aim of this study was to compare the efficacy and safety of the prodrug psychostimulant lisdexamfetamine dimesylate (LDX) and the non-stimulant noradrenergic compound atomoxetine (ATX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) who had previously...

Descripción completa

Detalles Bibliográficos
Autores principales: Dittmann, Ralf W., Cardo, Esther, Nagy, Peter, Anderson, Colleen S., Bloomfield, Ralph, Caballero, Beatriz, Higgins, Nicholas, Hodgkins, Paul, Lyne, Andrew, Civil, Richard, Coghill, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835923/
https://www.ncbi.nlm.nih.gov/pubmed/23959815
http://dx.doi.org/10.1007/s40263-013-0104-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835923/
https://www.ncbi.nlm.nih.gov/pubmed/23959815
http://dx.doi.org/10.1007/s40263-013-0104-8

Ejemplares similares